Search - tctmd.com

Displaying 861 - 880 of 1553

Sort: Relevancy | Date

Presentation TCT 2017

Do Patients Really Do Better When Their Cardiologists Are Away at Conferences? Embedding Controls in Observational Studies

Presenter: Robert A. Harrington, Sanjay Kaul, Robert W. Yeh

October 30, 2017

Presentation TCT 2017

Assessment of the Quality and Reliability of Meta-analysis (Summary Level, Network, and Individual Patient Data-Based)

Presenter: Robert A. Harrington, Sanjay Kaul, Giuseppe Biondi-Zoccai

October 30, 2017

Presentation TCT 2017

Natures Randomized Trials: Natural Experiments, Instrumental Variables, and Mendelian Randomization (Strengths and Limitations)

Presenter: Robert A. Harrington, Sanjay Kaul, Robert W. Yeh

October 30, 2017

Presentation TCT 2017

The Worst Misinterpretations Ive Seen in Observational Research Studies: How to Spot Them, How to Avoid Them

Presenter: Robert A. Harrington, Sanjay Kaul

October 30, 2017

Presentation TCT 2017

EFS Experiences and Recommendations: A Major Device Company Perspective

Presenter: Andrew Farb, Aaron V. Kaplan, Donald E. Bobo Jr

October 30, 2017

Presentation TCT 2017

EFS Experiences and Recommendations: A Start-up Perspective

Presenter: Andrew Farb, Aaron V. Kaplan, Rick Geoffrion

October 30, 2017

Presentation TCT 2017

Early Feasibility Studies in the USA: Success, Hurdles, and Future Pathways

Presenter: Andrew Farb, Aaron V. Kaplan, Jaime Walkowiak

October 30, 2017

Presentation TCT 2017

Early Feasibility Studies in USA: Status Update Report from the FDA

Presenter: Andrew Farb, Aaron V. Kaplan

October 30, 2017

Presentation TCT 2017

EFS: Articulating the Value for the Entire Ecosystem

Presenter: Andrew Farb, Aaron V. Kaplan

October 30, 2017

Presentation TCT 2017

Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of Women

Presenter: Wayne B. Batchelor, George A. Mensah, Roxana Mehran

October 30, 2017

Presentation TCT 2017

Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of African American/Latina Populations

Presenter: Wayne B. Batchelor, George A. Mensah

October 30, 2017

Presentation TCT 2017

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: SCAI

Presenter: Wayne B. Batchelor, George A. Mensah, Cindy L. Grines

October 30, 2017

Presentation TCT 2017

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: STS/AATS

Presenter: Wayne B. Batchelor, George A. Mensah, Vinod H. Thourani

October 30, 2017

Presentation TCT 2017

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: AHA

Presenter: Wayne B. Batchelor, George A. Mensah, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: ACC

Presenter: Wayne B. Batchelor, George A. Mensah, Pamela S. Douglas

October 30, 2017

Presentation TCT 2017

The Landscape of CV Device Innovation for Children: Regulatory View

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Sara Takahashi

October 30, 2017

Presentation TCT 2017

FDA Perspectives: Diversity in Clinical Trials and its Impact of Device Evaluation

Presenter: Wayne B. Batchelor, George A. Mensah, Christopher J Popma

October 30, 2017

Presentation TCT 2017

The Landscape of CV Device Innovation for Children: Regulatory View

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Nicole Milligan

October 30, 2017

Presentation TCT 2017

The Landscape of CV Device Innovation for Children: Industry View

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Lisa Becker

October 30, 2017

Presentation TCT 2017

CMS Perspectives on Post-Approval Device Evaluation(Including NEST) and Reimbursement

Presenter: Mitchell W. Krucoff, John C Laschinger, Daniel A Canos

October 30, 2017

Advertisement

Do Patients Really Do Better When Their Cardiologists Are Away at Conferences? Embedding Controls in Observational Studies

Assessment of the Quality and Reliability of Meta-analysis (Summary Level, Network, and Individual Patient Data-Based)

Natures Randomized Trials: Natural Experiments, Instrumental Variables, and Mendelian Randomization (Strengths and Limitations)

The Worst Misinterpretations Ive Seen in Observational Research Studies: How to Spot Them, How to Avoid Them

EFS Experiences and Recommendations: A Major Device Company Perspective

EFS Experiences and Recommendations: A Start-up Perspective

Early Feasibility Studies in the USA: Success, Hurdles, and Future Pathways

Early Feasibility Studies in USA: Status Update Report from the FDA

EFS: Articulating the Value for the Entire Ecosystem

Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of Women

Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of African American/Latina Populations

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: SCAI

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: STS/AATS

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: AHA

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: ACC

The Landscape of CV Device Innovation for Children: Regulatory View

FDA Perspectives: Diversity in Clinical Trials and its Impact of Device Evaluation

The Landscape of CV Device Innovation for Children: Regulatory View

The Landscape of CV Device Innovation for Children: Industry View

CMS Perspectives on Post-Approval Device Evaluation(Including NEST) and Reimbursement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content